Last reviewed · How we verify
High-dose Dexamethasone Plus Hetrombopag vs High-dose Dexamethasone Alone as Frontline Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial
The project was undertaking by Qilu Hospital of Shandong University in China. In order to report the efficacy and safety of Hetrombopag plus high-dose dexamethasone for the treatment of adults with newly-diagnosed primary immune thrombocytopenia (ITP).
Details
| Lead sponsor | Shandong University |
|---|---|
| Phase | PHASE2 |
| Status | UNKNOWN |
| Enrolment | 100 |
| Start date | Fri Sep 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- ITP - Immune Thrombocytopenia
Interventions
- hetrombopag 5mg po qd
- High-dose Dexamethasone
Countries
China